Target intelligence / Profile preview

Keratin 8 pseudogene 43 (KRT8P43)

Target
KRT8P43
Molecular classification
Other (Pseudogene)
01

Overview

Keratin 8 pseudogene 43 (KRT8P43) is annotated in genome databases as a pseudogene, meaning it is a DNA sequence similar to the protein-coding keratin 8 gene but is non-functional because it cannot be transcribed into a biologically active protein. It does not encode any known protein, does not have established biological functions, and is not associated with diseases or therapeutic targeting. Pseudogenes arise through duplication or mutation and can be used as markers in genomic studies but have no direct clinical or pharmacological relevance[5][7].

Beyond the preview

Go deeper on Keratin 8 pseudogene 43 (KRT8P43).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Keratin 8 pseudogene 43 (KRT8P43).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call